| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3277931
Max Phase: Preclinical
Molecular Formula: C26H25ClN4O2
Molecular Weight: 424.50
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cl.N=C(N)c1ccc(COc2ccc3ccc(OCc4ccc(C(=N)N)cc4)cc3c2)cc1
Standard InChI: InChI=1S/C26H24N4O2.ClH/c27-25(28)20-5-1-17(2-6-20)15-31-23-11-9-19-10-12-24(14-22(19)13-23)32-16-18-3-7-21(8-4-18)26(29)30;/h1-14H,15-16H2,(H3,27,28)(H3,29,30);1H
Standard InChI Key: FROPFDDVFWXSOM-UHFFFAOYSA-N
Associated Targets(Human)
Thrombin 11687 Activities
Plasma 7708 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Thrombin 1630 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Glandular kallikrein 81 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 424.50 | Molecular Weight (Monoisotopic): 424.1899 | AlogP: 4.57 | #Rotatable Bonds: 8 |
| Polar Surface Area: 118.20 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 11.77 | CX LogP: 3.94 | CX LogD: -0.87 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.24 | Np Likeness Score: -0.15 |
References
| 1. Geratz JD, Cheng MC, Tidwell RR.. (1976) Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement., 19 (5): [PMID:1271404] [10.1021/jm00227a011] |
Source
Source(1):